key: cord-0743257-cvwpskwk authors: Pei, Yigang; Liu, Wenguang; Masokano, Ismail Bilal; Li, Fang; xie, Simin; Zhou, Gaofeng; Long, Xueying; Liao, Weihua; Hu, Shuo; Li, Wenzheng title: Comparing Chinese children and adults with RT-PCR positive COVID-19: A systematic review date: 2020-07-13 journal: J Infect Public Health DOI: 10.1016/j.jiph.2020.06.036 sha: 2f9efabb212b6c9f998c2710131bfaadeb02acc7 doc_id: 743257 cord_uid: cvwpskwk BACKGROUND: The various clinical manifestations of COVID-19 with RT-PCR positive patients have been reported. However, the differences in the clinical presentation between children and adults were unclear. Thus, we aimed to investigate the differences in the clinical manifestations and imaging characteristics between Chinese children and adults with COVID-19 by systematically analyzing the data derived from some latest literatures. METHODS: An extensive search of COVID-19 papers was conducted in PubMed and Chinese medical journal network, and relevant articles were selected based on some standard requirements. The included papers were analyzed for differences in clinical manifestation between children and adults with COVID-19 after the quality evaluation with the QUADAS-2 tool. The differences in the clinical features and CT findings were analyzed using a Pearson χ(2) test or Fisher's exact test. Patients who underwent CT examination were divided into the initial examination (0-4days) and follow-up examination groups (5-14 days). RESULTS: A total of 345patients (70 children and 275 adults) with RT- PCR (+) were included in our study (5 papers for children and 5 papers for adult groups). Significant differences between children and adults were found in exposure history ( p < 0.001, χ(2) = 166.890), fever ( p=,0.016, χ(2) = 5.757), white cell count ( p < 0.001, χ(2) = 14.043), and CT features in the initial ( p < 0.001, χ(2) = 60.653) and follow-up stages ( p < 0.001, χ(2) = 52.924); and the involved lung in the follow-up stage ( p＜0.001, χ(2) = 16.776). CONCLUSIONS: Some differences have been presented between children and adults with RT-PCR positive COVID-19, which are helpful in the management and protection of children with COVID-19. It is unfortunate for the Chinese that their cheerful spring festival has been ruined by the sudden 2019 novel coronavirus attack, which started from the city of Wuhan, Hubei province, China, and then spread rapidly to other cities and countries such as Vietnam, South Korea, and the USA [1, 2] . Coronavirus disease , as is currently referred to by the World Health Organization (WHO), is posing a significant threat to international health. By 18:00 on March 11, 2020, WHO has reported 80981 confirmed cases in China, and 46725 confirmed cases in other countries. Unfortunately, about 900 children were included in the disaster [3] . Currently, some characteristics regarding the clinical presentation, computed tomography (CT) images and epidemiology that are very vital to the development of a treatment guideline for COVID- 19 have been reported [4] [5] [6] . However, to our J o u r n a l P r e -p r o o f knowledge, the differences between children and adults in the clinical manifestation of COVID-19 is unclear. Therefore, the purpose of our study is to investigate the key differences in COVID-19 presentation between Chinese children and adults by systematically analyzing the data obtained from some latest literatures. Our findings will be useful in the development of a management plan and choosing an individualized therapy method for the protection of children with COVID-19. We searched MEDLINE (PubMed, https://www.ncbi.nlm.nih.gov/pubmed/) and the Chinese medical journal network (http://medjournals.cn/index.do) for potential studies published before March 3, 2020, using the following terms: (COVID- 19) , (SARS-COV-2), (2019-nCOV), (novel coronavirus disease) or (novel coronavirus pneumonia). Then, a manual search of the reference lists of all retrieved articles was performed to obtain additional studies. COVID-19 Studies were screened by Yigang Pei and Wenguang Liu based on the following criteria: 1) the paper was primary research or a case report that focused on the clinical and CT features of children and adults with an RT-PCR positive COVID-19 and published within the last 40 days. 2 ) the study's demographics were exclusively Chinese to avoid distortions caused by racial differences, 3) the paper must come from different institutions in China to avoid data overlap. For papers from the J o u r n a l P r e -p r o o f same institution, the article that best meets our criteria was included. Finally, EndNote Reference Manager software was used to remove all duplicates, and relevant papers were divided into the children and adult groups according to the titles and article abstracts (children: 0-18 old years, Adults: > 18 old years) (Fig 1) . We (Yigang Pei and Wenguang Liu) extracted article related data such as the first author, the date of publication, the corresponding author's institution, and region. We collected participant related data that constituted of gender and age, the exposure history (1. J o u r n a l P r e -p r o o f living in Wuhan, 2. recent travel to Wuhan within two weeks, 3. cluster or exposure to infected patient(s), 4. unknown exposure), clinical symptoms (1. asymptomatic, 2. fever, 3 . cough, 4. myalgia or fatigue, 5. sputum production or expectoration, 6. dyspnea, 7. The data were used to assess the key differences between adults and children. Quality assessment was conducted on this particular review with the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) [7] . The QUADAS-2 format includes four key domains: 1) patient selection, 2) index test, 3) reference standard, and 4) flow and timing (http://www.bristol.ac.uk/population-healthsciences/projects/quadas/quadas-2/). For these domains, the risk of bias and concerns about applicability (the fourth domain not applying for the applicability) were analyzed and rated as a low, high or unclear risk. The results of the quality assessment were used for descriptive purposes to provide an evaluation of the overall quality of the included studies and to investigate potential sources of heterogeneity. Two authors (Yigang Pei and Wenguang Liu) independently evaluated the methodological quality, using a J o u r n a l P r e -p r o o f standard form with quality assessment criteria and a flow diagram. The disagreements were resolved by discussion between them to reach a consensus (Table 1) [4, [8] [9] [10] [11] [12] [13] [14] [15] [16] . Risk of bias and applicability concerns graphs were drawn using RevMan (RevMan 5.3, Cochrane Collaboration, Oxford, UK) (Fig 2) . The methodology of quality criteria was based on: the description of the inclusion and The statistical heterogeneity of studied paper was evaluated by Yigang Pei and Wenguang Liu. All data were statistically analyzed using SPSS (SPSS for Windows, version 18.0; SPSS, Chicago, IL) in our study. The comparison of discrete variables between groups was performed using the Pearson χ2 test or Fisher's exact test. P < 0.05 was regarded as statistically significant. A total of 345 patients with RT-PCR(+) were included to assess the differences between children and adults with COVID-19, including 70 children and 275 adults obtained from 10 articles that met the requirements of our study (Children: 5 papers, Adults: 5 papers). There was a significant difference in exposure history between children and adults (p<0.001, χ 2 = 166.890). There was a significant difference in white cell count between children and adults except for 2 children (reference 11, 13) and 121 adults (reference 4) who had no details on white blood cell count information (p < 0.001, χ 2 = 14.043) ( Table 2 ). Ground-glass opacity (GGO), consolidation and crazy-paving were the main characteristic features on CT images (Fig 3) . The significant differences between children and adults were found in the first examination ( p < 0.001, χ 2 = 60.553) and (Table 3) . Additionally, three children primarily underwent X-ray in some of the studies. 84 adults and 36 children were discharged from the hospital. However, in reference 10 (paper 3) and reference 4( paper 4), discharge status was unclear (Fig 4) . In addition, A total of 3 adults died (no mortality in the children group) from the referencesexcept for references 10 and 14 who had no mortality record. Based on our data analysis, we found that the main exposure history for adults is living in or recent travel to Wuhan. In contrast, the most common exposure history for children is family clustering. This hinted the need to observe the child and carry out a nucleic acid testing, even if asymptomatic, whenever a family member is diagnosed with COVID-19. Thus, asymptomatic children need to start personalized therapy as soon as possible before worsening of the disease condition. Jasper Fuk-Woo et al. reported a child without any symptom to have accepted treatment when he tested positive for the RT-PCR [17] . In our collected data, 14 children (20.0%) and 15 (5.5%) adults were asymptomatic with positive nucleic acid tests. Consistent with other literature reports, fever is the most common clinical symptom in both children and adults with COVID-19 [18] [19] [20] . In our study, the incidence rate of fever was over 50% at the time of presentation (Children: 40 (57.1%), Adults: 198 (72.0%) ). A recent study found that fever was only 43.8% for patients on admission in 1099 subjects confirmed with COVID-19 [20] . Interestingly, the proportion of children J o u r n a l P r e -p r o o f with no fever (30/70, 42.9%) is significantly higher than that of adults (77/275, 28.0%) in our data. We speculate that the possible reason is that children's immunity is weaker than that of adults, and the protective physical symptoms such as fever do not occur easily. Furthermore, children have fewer other clinical symptoms than adults, such as cough, myalgia, fatigue, cardiovascular, and cerebrovascular diseases suggesting that children have a better prognosis compared to adult patients. In this study, there was a significant difference in white cell count between children and adults. White blood cell counts were normal or low in all children but high in some adults. The reason was that there were more severe cases in adults than in children from several studies reviewed [9, 21] . The adults had some comorbidities such as diabetes and cerebrovascular diseases that can decrease immunity and lead to an increase in the white blood cells. High-resolution chest CT is recommended as the key component for the diagnostic work-up of COVID-19 patients because it can clearly display the lesions in the involved lung [22] . Characteristic CT features differ in various stages and consist of varying proportions of ground-glass opacity (GGO), consolidation and(or) crazy-paving in the peripheral lung [8, 23] . Imaging features of COVID-19 are similar to SARS and MERS because the virus family shares similar pathogenesis [22] . In adults, the dominating CT characteristic was GGO in the initial stage (0 -4 days) and consolidation in the followup stage (5 -14 days) . This finding implies that the follow-up stage can cause obvious inflammatory reactions leading to the accumulation of a large number of inflammatory exudates in the alveoli [24] . Also, COVID-19 was complicated by bilateral pneumonia J o u r n a l P r e -p r o o f in 69.2% of pediatric and 60.0% of adult cases within 0 -4 days, and in 41.7% of pediatric and 87.8% of adult cases in the follow-up stage (5 -14 days). We speculate that adult subjects having some background diseases can further develop bilateral multiple ground-glass opacities, infiltrating shadows, and pulmonary consolidation, with infrequent pleural effusion. Thus, there are more severe cases in adults than in children, which commonly presents as bilateral pneumonia in the follow-up stage [9] . During follow-up, there were more pediatric cases with a gradual recovery of lesions and a relatively better prognosis. Furthermore, three children primarily underwent Chest X-ray in our data, which showed multiple small patchy shadows and interstitial changes [25] . It is the first choice of imaging for children due to the low radiation level. Sometimes, it may be negative in the early stage of pneumonia cases, and a low dose of CT should thus be considered for children. For the management of COVID-19 patients, First, patients with COVID-19 should be treated in designated hospitals with effective isolation and protection conditions. Second, they should rest in bed and be closely monitored for: vital signs (heart rate, respiratory rate, blood pressure, pulse oxygen saturation) and supervised for routine blood tests, C-reactive protein, procalcitonin, organic function tests (liver enzymes, bilirubin, myocardial enzyme, creatinine, urea nitrogen, urine volume, etc.), coagulation function, arterial blood gas analysis and chest imaging. In our data, all cases performed high-resolution chest CT. Third, patients should receive a supportive treatment to ensure sufficient energy intake, hydration, electrolytes and acid-base levels. Fourth, critical cases must be admitted into the intensive care unit as soon as possible J o u r n a l P r e -p r o o f and should receive effective oxygen therapy with a nasal catheter, an oxygen mask, a high-flow nasal oxygen therapy, non-invasive ventilation or invasive mechanical ventilation. Furthermore, Extracorporeal Membrane Oxygenation (ECMO) should be considered for patients with refractory hypoxia that is difficult to correct with protective lung ventilation [26] . There are some limitations to this study. First, the number of children included is relatively small because about 900 children have already been confirmed with the disease [3] and only a few papers were found. Second, all pediatric cases were obtained from Chinese journals with a low impact factor. However, the data is trustworthy because all cases were hospitalized in the best pediatric and famous general hospitals in the corresponding provinces of China. Finally, the total sample is not large enough, but significant in patients with COVID-19, especially in a pediatric case. In general, the child should be carefully cared for even if asymptomatic when a family member is diagnosed with COVID-19 because children with COVID-19 have some differences compared to adults in their exposure history, clinical symptoms, laboratory findings, and CT image characteristics. This finding will help establish a management plan and choose an individualized therapy for the prevention of COVID-19 and the protection of children. This work was supported by the Hunan Science and Technology Department Plan The first Vietnamese case of COVID-19 acquired from China Viral Load Kinetics SARS-CoV-2 Infection in First Two Patients in Korea Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention Chest CT Findings in Coronavirus Disease-19 (COVID-19): Relationship to Duration of Infection COVID-19): A Perspective from China Defining the Epidemiology of Covid-19 -Studies Needed QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Time Course of Lung Changes On Chest CT During Recovery From Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study Emerging Coronavirus 2019-nCoV Pneumonia Novel Coronavirus (COVID-19) Pneumonia: Serial Computed Tomography Findings Analysis of CT features of 15 Children with 2019 novel coronavirus infection First case of 2019 novel coronavirus infection in children in Shanghai 2019-novel coronavirus infection in a three-month-old baby High resolution CT features of novel coronavirus pneumonia in children Clinical analysis of 31 cases of 2019 novel coronavirus infection in children from six provinces (autonomous region) of northern China A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Clinical Characteristics of Coronavirus Disease 2019 in China Chest CT Findings in Patients with Corona Virus Disease 2019 and its Relationship with Clinical Features CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): a study of 63 patients in Wuhan, China Pathological findings of COVID-19 associated with acute respiratory distress syndrome Clinical features of patients infected with 2019 novel coronavirus in Wuhan A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version We declare no competing interests. This article uses published data, and ethics approval was not required. S Hu and WZ Li had the idea for and designed the study and participated in the entire process of the research. YG Pei and WG Liu collected the data, evaluated the risk of bias, and contributed to the writing of the paper with IB Masokano and Fang Li. S Hu, WZ Li and XY Long contributed to critical revision of the paper. WH Liao, SM Xie and GF Zhou contributed to the statistical analysis. All authors contributed to data screening, data analysis, or data interpretation, and reviewed and approved the final version.